Additional file 1: of The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures
BackgroundEchinoderm microtubule-associated protein-like 4 (EML4) is the canonical anaplastic lymphoma kinase (ALK) fusion partner in non-small cell lung cancer (NSCLC), and ALK-positive patients show
A synchronous genetically unrelated double B-cell lymphoma is currently unknown. Since DLBCL and MCL are treated differently, significant diagnostic procedures including extensive genetic analyses are
